Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Operating Leases (2022 - 2023)

Historic Operating Leases for Terns Pharmaceuticals (TERN) over the last 2 years, with Q3 2023 value amounting to $63000.0.

  • Terns Pharmaceuticals' Operating Leases fell 9102.56% to $63000.0 in Q3 2023 from the same period last year, while for Sep 2023 it was $63000.0, marking a year-over-year decrease of 9102.56%. This contributed to the annual value of $544000.0 for FY2022, which is N/A changed from last year.
  • According to the latest figures from Q3 2023, Terns Pharmaceuticals' Operating Leases is $63000.0, which was down 9102.56% from $223000.0 recorded in Q2 2023.
  • Terns Pharmaceuticals' Operating Leases' 5-year high stood at $1.0 million during Q1 2022, with a 5-year trough of $63000.0 in Q3 2023.